DISAMPING KANAN INI.............
PLEASE USE ........ "TRANSLATE MACHINE" .. GOOGLE TRANSLATE BESIDE RIGHT THIS
......................
Good
bacteria that protects against HIV identified
Good
bacteria that protects against HIV identified
Date:
March 28,
2014
Source:
University of Texas Medical Branch
at Galveston
Summary:
By growing vaginal skin cells outside the body and
studying the way they interact with 'good and bad' bacteria, researchers think
they may be able to better identify the good bacteria that protect women from
HIV infection and other sexually transmitted infections.
........................
Researchers
at the University of Texas Medical Branch at Galveston by growing vaginal skin
cells outside the body and studying the way they interact with "good and
bad" bacteria, think they may be able to better identify the good bacteria
that protect women from HIV infection and other sexually transmitted
infections.
The health
of the human vagina depends on a symbiotic/mutually beneficial relationship
with "good" bacteria that live on its surface feeding on products
produced by vaginal skin cells. These good bacteria, in turn, create a physical
and chemical barrier to bad bacteria and viruses including HIV.
A
publication released today from a team of scientists representing multiple
disciplines at UTMB and the Oak Crest Institute of Science in Pasadena, Calif.,
reports a new method for studying the relationship between the skin cells and the
"good" bacteria.
The
researchers are the first to grow human vaginal skin cells in a dish in a
manner that creates surfaces that support colonization by the complex good and
bad communities of bacteria collected from women during routine gynecological exams.
The bacteria communities have never before been successfully grown outside a
human.
The research
group led by Richard Pyles at UTMB reports in the journal PLOS One that
by using this model of the human vagina, they discovered that certain bacterial
communities alter the way HIV infects and replicates. Their laboratory model
will allow careful and controlled evaluation of the complex community of
bacteria to ultimately identify those species that weaken the defenses against
HIV. Pyles also indicated that this model "will provide the opportunity to
study the way that these mixed species bacterial communities change the
activity of vaginal applicants including over-the-counter products like douches
and prescription medications and contraceptives. These types of studies are
very difficult or even impossible to complete in women who are participating in
clinical trials."
In fact, the
team's report documented the potential for their system to better evaluate
current and future antimicrobial drugs in terms of how they interact with
"good and bad" bacteria. In their current studies a bacterial
community associated with a symptomatic condition called bacterial vaginosis
substantially reduced the antiviral activity of one of the leading anti-HIV
medicines.
Conversely,
vaginal surfaces occupied by healthy bacteria and treated with the antiviral
produced significantly less HIV than those vaginal surfaces without bacteria
treated with the same antiviral. Dr. Marc Baum, the lead scientist at Oak Crest
and co-author of the work, stated "this model is unique as it faithfully
recreates the vaginal environment ex vivo, both in terms of the host cellular
physiology and the associated complex vaginal microbiomes that could not
previously be cultured. I believe it will be of immense value in the study of
sexually transmitted infections."
Story
Source:
The above
story is based on materials provided by University of Texas Medical Branch at Galveston. Note:
Materials may be edited for content and length.
Journal
Reference:
- Richard B. Pyles, Kathleen L. Vincent, Marc M. Baum, Barry Elsom, Aaron L. Miller, Carrie Maxwell, Tonyia D. Eaves-Pyles, Guangyu Li, Vsevolod L. Popov, Rebecca J. Nusbaum, Monique R. Ferguson. Cultivated Vaginal Microbiomes Alter HIV-1 Infection and Antiretroviral Efficacy in Colonized Epithelial Multilayer Cultures. PLoS ONE, 2014; 9 (3): e93419 DOI: 10.1371/journal.pone.0093419